Cargando…

Mathematical models for translational and clinical oncology

In the context of translational and clinical oncology, mathematical models can provide novel insights into tumor-related processes and can support clinical oncologists in the design of the treatment regime, dosage, schedule, toxicity and drug-sensitivity. In this review we present an overview of mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallasch, Ralf, Efremova, Mirjana, Charoentong, Pornpimol, Hackl, Hubert, Trajanoski, Zlatko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828625/
https://www.ncbi.nlm.nih.gov/pubmed/24195863
http://dx.doi.org/10.1186/2043-9113-3-23
_version_ 1782291271531888640
author Gallasch, Ralf
Efremova, Mirjana
Charoentong, Pornpimol
Hackl, Hubert
Trajanoski, Zlatko
author_facet Gallasch, Ralf
Efremova, Mirjana
Charoentong, Pornpimol
Hackl, Hubert
Trajanoski, Zlatko
author_sort Gallasch, Ralf
collection PubMed
description In the context of translational and clinical oncology, mathematical models can provide novel insights into tumor-related processes and can support clinical oncologists in the design of the treatment regime, dosage, schedule, toxicity and drug-sensitivity. In this review we present an overview of mathematical models in this field beginning with carcinogenesis and proceeding to the different cancer treatments. By doing so we intended to highlight recent developments and emphasize the power of such theoretical work. We first highlight mathematical models for translational oncology comprising epidemiologic and statistical models, mechanistic models for carcinogenesis and tumor growth, as well as evolutionary dynamics models which can help to describe and overcome a major problem in the clinic: therapy resistance. Next we review models for clinical oncology with a special emphasis on therapy including chemotherapy, targeted therapy, radiotherapy, immunotherapy and interaction of cancer cells with the immune system. As evident from the published studies, mathematical modeling and computational simulation provided valuable insights into the molecular mechanisms of cancer, and can help to improve diagnosis and prognosis of the disease, and pinpoint novel therapeutic targets.
format Online
Article
Text
id pubmed-3828625
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38286252013-11-16 Mathematical models for translational and clinical oncology Gallasch, Ralf Efremova, Mirjana Charoentong, Pornpimol Hackl, Hubert Trajanoski, Zlatko J Clin Bioinforma Review In the context of translational and clinical oncology, mathematical models can provide novel insights into tumor-related processes and can support clinical oncologists in the design of the treatment regime, dosage, schedule, toxicity and drug-sensitivity. In this review we present an overview of mathematical models in this field beginning with carcinogenesis and proceeding to the different cancer treatments. By doing so we intended to highlight recent developments and emphasize the power of such theoretical work. We first highlight mathematical models for translational oncology comprising epidemiologic and statistical models, mechanistic models for carcinogenesis and tumor growth, as well as evolutionary dynamics models which can help to describe and overcome a major problem in the clinic: therapy resistance. Next we review models for clinical oncology with a special emphasis on therapy including chemotherapy, targeted therapy, radiotherapy, immunotherapy and interaction of cancer cells with the immune system. As evident from the published studies, mathematical modeling and computational simulation provided valuable insights into the molecular mechanisms of cancer, and can help to improve diagnosis and prognosis of the disease, and pinpoint novel therapeutic targets. BioMed Central 2013-11-07 /pmc/articles/PMC3828625/ /pubmed/24195863 http://dx.doi.org/10.1186/2043-9113-3-23 Text en Copyright © 2013 Gallasch et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Gallasch, Ralf
Efremova, Mirjana
Charoentong, Pornpimol
Hackl, Hubert
Trajanoski, Zlatko
Mathematical models for translational and clinical oncology
title Mathematical models for translational and clinical oncology
title_full Mathematical models for translational and clinical oncology
title_fullStr Mathematical models for translational and clinical oncology
title_full_unstemmed Mathematical models for translational and clinical oncology
title_short Mathematical models for translational and clinical oncology
title_sort mathematical models for translational and clinical oncology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828625/
https://www.ncbi.nlm.nih.gov/pubmed/24195863
http://dx.doi.org/10.1186/2043-9113-3-23
work_keys_str_mv AT gallaschralf mathematicalmodelsfortranslationalandclinicaloncology
AT efremovamirjana mathematicalmodelsfortranslationalandclinicaloncology
AT charoentongpornpimol mathematicalmodelsfortranslationalandclinicaloncology
AT hacklhubert mathematicalmodelsfortranslationalandclinicaloncology
AT trajanoskizlatko mathematicalmodelsfortranslationalandclinicaloncology